Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors

L. Puskás, F. Juhasz, A. Zvara, L. Hackler, N. R. Farid

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Thyroid nodules are common. It would very helpful if genetic markers that can diagnose malignancy from fine needle aspiration samples were available. Few such markers has been thus identified and none are specific. Large panels of potential markers can be screened by microarray technology. Studies done to date have concentrated on single tumor types and thus provide no help in identifying tumor subtype specific markers. To that end we have studied gene profiles of 5 types of benign and malignant thyroid nodular tissue (multinodular goiter, follicular adenoma, papillary and follicular carcinomas). We have identified 195 genes whose differential expression clustered into clinically relevant groups. Twenty-eight genes were selected for further confirmation using real time quantitative polymerase chain reaction. Despite the differences in the microarray panels used, we confirmed the differential regulation of 12 genes previously reported in thyroid cancer, although we found the expression of several genes to be regulated in other histological tumor subtypes than originally described. We found, PCSK2, TRIB1, RAP1 GA1 to be specifically overexpressed in follicular cancer and S100A4 and GK2 in papillary carcinoma. SERP1, RNASE 2 and STATA5 were suppressed in papillary thyroid cancer. We have thus identified new potential markers specific to malignant thyroid tumors. It is apparent that a range of nodular thyroid tissue using large tumor sample numbers is necessary to establish robust markers for malignancy and to categorize tumors on the basis of small tumor samples.

Original languageEnglish
Pages (from-to)177-186
Number of pages10
JournalCellular and Molecular Biology
Volume51
Issue number2
Publication statusPublished - Sep 5 2005

Fingerprint

Tumors
Thyroid Gland
Genes
Neoplasms
Microarrays
Tissue
Polymerase chain reaction
Carcinoma, Papillary, Follicular
Needles
Thyroid Nodule
Papillary Carcinoma
Goiter
Fine Needle Biopsy
Genetic Markers
Thyroid Neoplasms
Adenoma
Real-Time Polymerase Chain Reaction
Technology
Gene Expression

Keywords

  • Fine needle biopsy
  • Follicular adenoma
  • Follicular carcinoma
  • Gene profiling
  • Microarrays
  • Multinodular goiter
  • Papillary carcinoma

ASJC Scopus subject areas

  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors. / Puskás, L.; Juhasz, F.; Zvara, A.; Hackler, L.; Farid, N. R.

In: Cellular and Molecular Biology, Vol. 51, No. 2, 05.09.2005, p. 177-186.

Research output: Contribution to journalArticle

@article{aa911397e61942cf9c2026b430b7ebef,
title = "Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors",
abstract = "Thyroid nodules are common. It would very helpful if genetic markers that can diagnose malignancy from fine needle aspiration samples were available. Few such markers has been thus identified and none are specific. Large panels of potential markers can be screened by microarray technology. Studies done to date have concentrated on single tumor types and thus provide no help in identifying tumor subtype specific markers. To that end we have studied gene profiles of 5 types of benign and malignant thyroid nodular tissue (multinodular goiter, follicular adenoma, papillary and follicular carcinomas). We have identified 195 genes whose differential expression clustered into clinically relevant groups. Twenty-eight genes were selected for further confirmation using real time quantitative polymerase chain reaction. Despite the differences in the microarray panels used, we confirmed the differential regulation of 12 genes previously reported in thyroid cancer, although we found the expression of several genes to be regulated in other histological tumor subtypes than originally described. We found, PCSK2, TRIB1, RAP1 GA1 to be specifically overexpressed in follicular cancer and S100A4 and GK2 in papillary carcinoma. SERP1, RNASE 2 and STATA5 were suppressed in papillary thyroid cancer. We have thus identified new potential markers specific to malignant thyroid tumors. It is apparent that a range of nodular thyroid tissue using large tumor sample numbers is necessary to establish robust markers for malignancy and to categorize tumors on the basis of small tumor samples.",
keywords = "Fine needle biopsy, Follicular adenoma, Follicular carcinoma, Gene profiling, Microarrays, Multinodular goiter, Papillary carcinoma",
author = "L. Pusk{\'a}s and F. Juhasz and A. Zvara and L. Hackler and Farid, {N. R.}",
year = "2005",
month = "9",
day = "5",
language = "English",
volume = "51",
pages = "177--186",
journal = "Cellular and Molecular Biology",
issn = "0145-5680",
publisher = "Cellular and Molecular Biology Association",
number = "2",

}

TY - JOUR

T1 - Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors

AU - Puskás, L.

AU - Juhasz, F.

AU - Zvara, A.

AU - Hackler, L.

AU - Farid, N. R.

PY - 2005/9/5

Y1 - 2005/9/5

N2 - Thyroid nodules are common. It would very helpful if genetic markers that can diagnose malignancy from fine needle aspiration samples were available. Few such markers has been thus identified and none are specific. Large panels of potential markers can be screened by microarray technology. Studies done to date have concentrated on single tumor types and thus provide no help in identifying tumor subtype specific markers. To that end we have studied gene profiles of 5 types of benign and malignant thyroid nodular tissue (multinodular goiter, follicular adenoma, papillary and follicular carcinomas). We have identified 195 genes whose differential expression clustered into clinically relevant groups. Twenty-eight genes were selected for further confirmation using real time quantitative polymerase chain reaction. Despite the differences in the microarray panels used, we confirmed the differential regulation of 12 genes previously reported in thyroid cancer, although we found the expression of several genes to be regulated in other histological tumor subtypes than originally described. We found, PCSK2, TRIB1, RAP1 GA1 to be specifically overexpressed in follicular cancer and S100A4 and GK2 in papillary carcinoma. SERP1, RNASE 2 and STATA5 were suppressed in papillary thyroid cancer. We have thus identified new potential markers specific to malignant thyroid tumors. It is apparent that a range of nodular thyroid tissue using large tumor sample numbers is necessary to establish robust markers for malignancy and to categorize tumors on the basis of small tumor samples.

AB - Thyroid nodules are common. It would very helpful if genetic markers that can diagnose malignancy from fine needle aspiration samples were available. Few such markers has been thus identified and none are specific. Large panels of potential markers can be screened by microarray technology. Studies done to date have concentrated on single tumor types and thus provide no help in identifying tumor subtype specific markers. To that end we have studied gene profiles of 5 types of benign and malignant thyroid nodular tissue (multinodular goiter, follicular adenoma, papillary and follicular carcinomas). We have identified 195 genes whose differential expression clustered into clinically relevant groups. Twenty-eight genes were selected for further confirmation using real time quantitative polymerase chain reaction. Despite the differences in the microarray panels used, we confirmed the differential regulation of 12 genes previously reported in thyroid cancer, although we found the expression of several genes to be regulated in other histological tumor subtypes than originally described. We found, PCSK2, TRIB1, RAP1 GA1 to be specifically overexpressed in follicular cancer and S100A4 and GK2 in papillary carcinoma. SERP1, RNASE 2 and STATA5 were suppressed in papillary thyroid cancer. We have thus identified new potential markers specific to malignant thyroid tumors. It is apparent that a range of nodular thyroid tissue using large tumor sample numbers is necessary to establish robust markers for malignancy and to categorize tumors on the basis of small tumor samples.

KW - Fine needle biopsy

KW - Follicular adenoma

KW - Follicular carcinoma

KW - Gene profiling

KW - Microarrays

KW - Multinodular goiter

KW - Papillary carcinoma

UR - http://www.scopus.com/inward/record.url?scp=30644471159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30644471159&partnerID=8YFLogxK

M3 - Article

C2 - 16171553

AN - SCOPUS:30644471159

VL - 51

SP - 177

EP - 186

JO - Cellular and Molecular Biology

JF - Cellular and Molecular Biology

SN - 0145-5680

IS - 2

ER -